European Heart Journal

• A Randomized Placebo-Controlled Study on the Effect of Nifedipine on Coronary Endothelial Function and Plaque Formation in Patients with Coronary Artery Disease: The ENCORE II Study Since endothelial dysfunction precedes atherosclerotic plaque formation, and nifedipine improves endothelial dysfunction, might the drug reduce plaque formation?
  European Heart Journal, October 2009
• Gender Differences in Sympathetic Neural Activation Following Uncomplicated Acute Myocardial Infarction Both sympatho-humoral activation and female gender are associated with worse outcome early after acute MI. Are the two risk factors related?
  European Heart Journal, October 2009
• Myocardial Bridging, a Frequent Component of the Hypertrophic Cardiomyopathy Phenotype, Lacks Systematic Association with Sudden Cardiac Death This study sought to clarify the clinical significance of myocardial bridging of the left anterior descending coronary artery in hypertrophic cardiomyopathy.
  European Heart Journal, October 2009
• Influence of Different Antiplatelet Treatment Regimens for Primary Percutaneous Coronary Intervention on All-Cause Mortality GP IIb/IIIa inhibitors, clopidogrel, or both can be used during PCI. Does the choice matter?
  European Heart Journal, October 2009
• Patients with Prior Coronary Artery Bypass Grafting Have a Poor Outcome after Myocardial Infarction: An Analysis of the VALsartan In Acute myocardial iNfarcTion Trial (VALIANT) Resurgent CAD and acute coronary syndrome after CABG is an increasingly common problem. How bad is the prognosis for these patients?
  European Heart Journal, October 2009
• Does IQ Explain Socio-Economic Differentials in Total and Cardiovascular Disease Mortality? Could your score on IQ testing literally be a matter of life or death?
  European Heart Journal, October 2009
• Socioeconomic Status, Blood Pressure Progression, and Incident Hypertension in a Prospective Cohort of Female Health Professionals Does socioeconomic status have a cardiovascular price for women?
  European Heart Journal, October 2009
• Drug Eluting or Bare Metal Stent for Acute Myocardial Infarction: An Issue of Safety? The short-term benefits of drug-eluting stents in acute MI might be outweighed by the long-term risks associated with late stent thrombosis.
  European Heart Journal, October 2009
• Randomized Study on the Efficacy of Immunosuppressive Therapy in Patients with Virus-Negative Inflammatory Cardiomyopathy: the TIMIC Study
  European Heart Journal, October 2009
• The Consistency of the Treatment Effect of an ACE-Inhibitor Based Treatment Regimen in Patients with Vascular Disease or High Risk of Vascular Disease ACE inhibitors reduce cardiovascular risk in several specific settings. This meta-analysis explores the possibility that these benefits apply to the broad group of patients with vascular disease.
  European Heart Journal, September 2009
• Personalized Medicine and Antiplatelet Therapy: Ready for Prime Time? Genes, illness, and environmental factors all help determine how well a particular antiplatelet drug will work in a given patient.
  European Heart Journal, August 2009
• Lipoprotein-Associated Phospholipase A2 Activity, Ferritin Levels, Metabolic Syndrome, and 10-year Cardiovascular and Non-Cardiovascular Mortality: Results From the Bruneck Study Does increased activity of lipoprotein-associated phospholipase A2 predict cardiovascular disease?
  European Heart Journal, July 2009
• Has There Been any Progress Made on Pregnancy Outcomes Among Women with Pulmonary Arterial Hypertension? Idiopathic pulmonary hypertension is associated with prohibitive maternal mortality; this systematic review details the problem along with suggestions for prevention.
  European Heart Journal, March 2009
• Efficacy of the I(f) Current Inhibitor Ivabradine In Patients With Chronic Stable Angina Receiving Beta-Blocker Therapy: A 4-Month, Randomized, Placebo-Controlled Trial Does adding ivabradine to atenolol provide better control of chronic stable angina, and is it safe?
  European Heart Journal, March 2009
• Incidence, Determinants, and Prognostic Value of Reverse Left Ventricular Remodeling After Primary Percutaneous Coronary Intervention Reverse LVR frequently occurs in STEMI patients treated with primary PCI. What does it signify?
  European Heart Journal, March 2009
• Mortality Following Placement of Drug-Eluting and Bare-Metal Stents for ST-segment Elevation Acute Myocardial Infarction in the Global Registry of Acute Coronary Events In patients with STEMI, which type of stent is associated with better outcomes?
  European Heart Journal, February 2009
• A Meta-Analysis of Randomized Controlled Trials in Pulmonary Arterial Hypertension This meta-analysis reviews survival in the patients treated with the targeted therapies approved for pulmonary arterial hypertension.
  European Heart Journal, February 2009
• Controversial Role of Plant Sterol Esters in the Management of Hypercholesterolemia In 2005, $3 billion was spent worldwide on foods supplemented with phytosterols. Such foods have approved health claims for the management of cholesterol. But are plant sterols helpful? And safe?
  European Heart Journal, February 2009
• Patients with Peripheral Arterial Disease in the CHARISMA Trial Does the combination of clopidogrel and aspirin provide greater protection against major cardiovascular events than aspirin alone in patients with peripheral arterial disease?
  European Heart Journal, January 2009
• Effects of Annual Influenza Vaccination on Winter Mortality in Elderly People With Chronic Heart Disease Annual flu vaccination is recommended for the elderly, but do elderly persons with chronic heart disease (CHD) have the same mortality risk as their counterparts who do not receive a flu shot?
  European Heart Journal, January 2009